Sivakumaran D, Jenum S, Srivastava A, Steen VM, Vaz M, Doherty TM, Ritz C, Grewal HMS(2023) Host blood-based biosignatures for subclinical TB and incipient TB: A prospective study of adult TB household contacts in Southern India Front Immunol, 13, 1051963 DOI 10.3389/fimmu.2022.1051963, PubMed 36713386
Trøseid M, Arribas JR, Assoumou L, Holten AR, Poissy J, Terzić V, Mazzaferri F, Baño JR, Eustace J, Hites M, Joannidis M, Paiva JA, Reuter J, Püntmann I, Patrick-Brown TDJH, Westerheim E, Nezvalova-Henriksen K, Beniguel L, Dahl TB, Bouscambert M, Halanova M, Péterfi Z, Tsiodras S, Rezek M, Briel Met al.(2023) Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial Crit Care, 27(1), 9 DOI 10.1186/s13054-022-04205-8, PubMed 36627655
Olsen MB, Huse C, de Sousa MML, Murphy SL, Sarno A, Obermann TS, Yang K, Holter JC, Jørgensen MJ, Christensen EE, Wang W, Ji P, Heggelund L, Hoel H, Dyrhol-Riise AM, Gregersen I, Aukrust P, Bjørås M, Halvorsen B, Dahl TB(2022) DNA Repair Mechanisms are Activated in Circulating Lymphocytes of Hospitalized Covid-19 Patients J Inflamm Res, 15, 6629-6644 DOI 10.2147/JIR.S379331, PubMed 36514358